PUBLISHER: Transparency Market Research | PRODUCT CODE: 1769919
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1769919
U.S Ambulatory Infusion Centers Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
U.S Ambulatory Infusion Centers Market - Scope of Report
TMR's report on the U.S ambulatory infusion centers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the U.S ambulatory infusion centers market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the U.S ambulatory infusion centers market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ambulatory infusion centers market.
| Market Snapshot | |
|---|---|
| Market Value in 2024 | US$ 8.9 Bn |
| Market Value in 2035 | US$ 22.5 Bn |
| CAGR | 8.8% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the U.S ambulatory infusion centers market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the U.S ambulatory infusion centers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the U.S ambulatory infusion centers market.
The report delves into the competitive landscape of the U.S ambulatory infusion centers market. Key players operating in the U.S ambulatory infusion centers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the U.S ambulatory infusion centers market profiled in this report.
Key Questions Answered in U.S ambulatory infusion centers Market Report:
- What is the sales/revenue generated by ambulatory infusion centers across all regions during the forecast period?
- What are the opportunities in the U.S ambulatory infusion centers market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue U.Sly in 2035?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the U.S market?
U.S Ambulatory Infusion Centers Market - Research Objectives and Research Approach
The comprehensive report on the U.S ambulatory infusion centers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the U.S ambulatory infusion centers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the U.S ambulatory infusion centers market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S Ambulatory Infusion Centers Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. U.S Ambulatory Infusion Centers Market Analysis and Forecast, 2020 to 2035
- 4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
- 5.1. Key Industry Events
- 5.2. List of Ambulatory Infusion Centers in United States - By Facility (Hospital Affiliated vs Non-affiliated)
- 5.3. Overview of Infusion Site of Care
- 5.4. Biosimilars and Specialty Injectables for Infusion Players
- 5.5. Infusion Competitive Landscape by Providers
- 5.6. Infusion Platform Transaction Activity (2021 and 2022)
- 5.7. PESTEL Analysis
- 5.8. Regulatory Scenario by Key Countries/Region
- 5.9. PORTER's Five Forces Analysis
- 5.10. Technological Advancements
- 5.11. Unmet Needs of the Market
6. U.S Ambulatory Infusion Centers Market Analysis and Forecast, by Type of Center
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Type of Center, 2020 to 2035
- 6.3.1. Hospital-based Infusion Centers
- 6.3.2. Physician-based Infusion Centers
- 6.3.3. Independent Infusion Centers
- 6.4. Market Attractiveness Analysis, by Type of Center
7. U.S Ambulatory Infusion Centers Market Analysis and Forecast, by Therapy Type
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Therapy Type, 2020 to 2035
- 7.3.1. Antibiotics
- 7.3.2. Blood Products
- 7.3.3. Nutritional Products
- 7.3.4. Immunosuppressants
- 7.3.5. Immunostimulants
- 7.3.6. Monoclonal antibodies
- 7.3.7. Immunoglobulin Therapy
- 7.3.8. Others
- 7.4. Market Attractiveness Analysis, by Therapy Type
8. U.S Ambulatory Infusion Centers Market Analysis and Forecast, by Disease Specialties
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by Disease Specialties, 2020 to 2035
- 8.3.1. Oncology
- 8.3.2. Pulmonology
- 8.3.3. Neurology
- 8.3.4. Gastrointestinal
- 8.3.5. Immunology
- 8.3.6. Cardiology
- 8.3.7. Others
- 8.4. Market Attractiveness Analysis, by Disease Specialties
9. Competition Landscape
- 9.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 9.2. Market Share Analysis, by Company (2023)
- 9.3. Company Profiles
- 9.3.1. Flexcare Infusion Centers
- 9.3.1.1. Company Overview
- 9.3.1.2. Financial Overview
- 9.3.1.3. Product Portfolio
- 9.3.1.4. Business Strategies
- 9.3.1.5. Recent Developments
- 9.3.2. Thrivewell
- 9.3.2.1. Company Overview
- 9.3.2.2. Financial Overview
- 9.3.2.3. Product Portfolio
- 9.3.2.4. Business Strategies
- 9.3.2.5. Recent Developments
- 9.3.3. Hy-Vee Health
- 9.3.3.1. Company Overview
- 9.3.3.2. Financial Overview
- 9.3.3.3. Product Portfolio
- 9.3.3.4. Business Strategies
- 9.3.3.5. Recent Developments
- 9.3.4. Agile Infusion Services LLC
- 9.3.4.1. Company Overview
- 9.3.4.2. Financial Overview
- 9.3.4.3. Product Portfolio
- 9.3.4.4. Business Strategies
- 9.3.4.5. Recent Developments
- 9.3.5. Infusion Solutions
- 9.3.5.1. Company Overview
- 9.3.5.2. Financial Overview
- 9.3.5.3. Product Portfolio
- 9.3.5.4. Business Strategies
- 9.3.5.5. Recent Developments
- 9.3.6. IVXpress, Inc.
- 9.3.6.1. Company Overview
- 9.3.6.2. Financial Overview
- 9.3.6.3. Product Portfolio
- 9.3.6.4. Business Strategies
- 9.3.6.5. Recent Developments
- 9.3.7. Infusion for Health
- 9.3.7.1. Company Overview
- 9.3.7.2. Financial Overview
- 9.3.7.3. Product Portfolio
- 9.3.7.4. Business Strategies
- 9.3.7.5. Recent Developments
- 9.3.8. Cedars-Sinai
- 9.3.8.1. Company Overview
- 9.3.8.2. Financial Overview
- 9.3.8.3. Product Portfolio
- 9.3.8.4. Business Strategies
- 9.3.8.5. Recent Developments
- 9.3.9. Arnot Health
- 9.3.9.1. Company Overview
- 9.3.9.2. Financial Overview
- 9.3.9.3. Product Portfolio
- 9.3.9.4. Business Strategies
- 9.3.9.5. Recent Developments
- 9.3.10. PharmaScript
- 9.3.10.1. Company Overview
- 9.3.10.2. Financial Overview
- 9.3.10.3. Product Portfolio
- 9.3.10.4. Business Strategies
- 9.3.10.5. Recent Developments
- 9.3.11. Naval Medical Center Portsmouth
- 9.3.11.1. Company Overview
- 9.3.11.2. Financial Overview
- 9.3.11.3. Product Portfolio
- 9.3.11.4. Business Strategies
- 9.3.11.5. Recent Developments
- 9.3.12. Valley Health Systems
- 9.3.12.1. Company Overview
- 9.3.12.2. Financial Overview
- 9.3.12.3. Product Portfolio
- 9.3.12.4. Business Strategies
- 9.3.12.5. Recent Developments
- 9.3.13. Cheyenne Regional Medical Center
- 9.3.13.1. Company Overview
- 9.3.13.2. Financial Overview
- 9.3.13.3. Product Portfolio
- 9.3.13.4. Business Strategies
- 9.3.13.5. Recent Developments
- 9.3.14. Pacific Medical Centers
- 9.3.14.1. Company Overview
- 9.3.14.2. Financial Overview
- 9.3.14.3. Product Portfolio
- 9.3.14.4. Business Strategies
- 9.3.14.5. Recent Developments
- 9.3.15. ChristianaCare
- 9.3.15.1. Company Overview
- 9.3.15.2. Financial Overview
- 9.3.15.3. Product Portfolio
- 9.3.15.4. Business Strategies
- 9.3.15.5. Recent Developments
- 9.3.1. Flexcare Infusion Centers
List of Tables
- Table 01: U.S Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020 to 2035
- Table 02: U.S Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Therapy Type, 2020 to 2035
- Table 03: U.S Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020 to 2035
List of Figures
- Figure 01: U.S Ambulatory Infusion Centers Market Value (US$ Bn) Forecast 2020 to 2035
- Figure 02: U.S Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
- Figure 03: U.S Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
- Figure 04: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Hospital-based Infusion Centers, 2020 to 2035
- Figure 05: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Physician-based Infusion Centers, 2020 to 2035
- Figure 06: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Independent Infusion Centers, 2020 to 2035
- Figure 07: U.S Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
- Figure 08: U.S Ambulatory Infusion Centers Market Attractiveness Analysis, by Therapy Type, 2025-2035
- Figure 09: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Antibiotics, 2020 to 2035
- Figure 10: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Blood Products, 2020 to 2035
- Figure 11: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Nutritional Products, 2020 to 2035
- Figure 12: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunosuppressants, 2020 to 2035
- Figure 13: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunostimulants, 2020 to 2035
- Figure 14: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Monoclonal antibodies, 2020 to 2035
- Figure 15: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunoglobulin Therapy, 2020 to 2035
- Figure 16: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Others, 2020 to 2035
- Figure 17: U.S Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
- Figure 18: U.S Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
- Figure 19: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Oncology, 2020 to 2035
- Figure 20: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Pulmonology, 2020 to 2035
- Figure 21: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Neurology, 2020 to 2035
- Figure 22: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Gastrointestinal, 2020 to 2035
- Figure 23: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunology, 2020 to 2035
- Figure 24: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Cardiology, 2020 to 2035
- Figure 25: U.S Ambulatory Infusion Centers Market Revenue (US$ Bn), by Others, 2020 to 2035
